Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 592 of 1,261
  1. US 9840520

    Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  2. US 9840483

    Radiomitigating pharmaceutical formulations

    The Regents of the University of California · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  3. US 9840493

    Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use

    Sutro Biopharma, Inc. · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  4. US 9839690

    Singlet oxygen-labile linkers and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  5. US 9839695

    Polymer-active agent conjugate

    Nektar Therapeutics · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  6. US 9839685

    Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  7. US 9839625

    Inhibition of cancer cell motility

    Northwestern University · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  8. US 9839684

    Pharmaceutical compositions comprising inactivated HIV viral particles and non-pathogenic lactobacilli for the induction of antigen-specific immunotolerance

    BIOVAXIM LIMITED · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  9. US 9839678

    Human tissue kallikrein 1 glycosylation isoforms

    DiaMedica Inc. · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  10. US 9839624

    Flavonoid compositions and methods of use

    Reoxcyn Discoveries Group, Inc. · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  11. US 9839636

    Itraconazole analogues and methods of use thereof

    UNIVERSITY OF CONNECTICUT · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  12. US 9840470

    Targeting GLI proteins in human cancer by small molecules

    The Regents of the University of California · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  13. US 2017349653

    METHODS FOR TREATING SPINAL CORD INJURY AND PAIN

    ABBVIE INC [US] · Granted Dec 7, 2017 · Expires Dec 2, 2037

    granted
  14. US 9833519

    Methods for the diagnosis and treatment of sjögren's syndrome

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted
  15. US 9833498

    Methods of treatment of collagen-mediated diseases and conditions

    HALOZYME, INC. · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted
  16. US 9834597

    Modified FC polypeptides, FC conjugates, and methods of use thereof

    The Regents of the University of California · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted
  17. US 9834568

    Kinase inhibitors and their uses

    Rigel Pharmaceuticals, Inc. · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted
  18. US 9833406

    Lubricant formulations

    Reoxcyn Discoveries Group, Inc. · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted
  19. US 9833457

    Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors

    VTV THERAPEUTICS LLC · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted
  20. US 9833437

    Small molecule inhibitor of MYD88 for therapeutic treatment against alphavirus and staphylococcal enterotoxin infections and toxin exposure

    The United States of America as represented by the Secretary of the Army · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted
  21. US 9834757

    Hand, foot, and mouth vaccines and methods of manufacture and use thereof

    Takeda Vaccines, Inc. · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted
  22. US 9834770

    Single stranded DNA aptamers binding NF-kB/RelA

    The Board of Regents of the University of Texas System · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted
  23. US 9833410

    Lyophilized formulation comprising GM-CSF neutralizing compound

    TAKEDA GMBH · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted
  24. US 9833421

    Method for synthesizing (E)-anethol and related compounds by cross coupling reaction of potassium allyltrifluroborate and 4-bromoanisole and aryl halides

    Tennessee Board of Regents · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.